Crystallization after intravitreous foscarnet injections.
Sebastián
S
Martínez-Castillo
Cristina
C
Marín-Lambíes
Roberto
R
Gallego-Pinazo
J Fernando
JF
Arévalo
Manuel
M
Díaz-Llopis
D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000737:chemistry*; D003460:Crystallization; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy; D005260:Female; D017245:Foscarnet / Q000008:administration & dosage / Q000009:adverse effects* / Q000737:chemistry*; D006801:Humans; D058449:Intravitreal Injections; D008875:Middle Aged; D041623:Tomography, Optical Coherence; D014792:Visual Acuity; D014822:Vitreous Body / Q000187:drug effects
D000998:Antiviral Agents; D017245:Foscarnet